trending Market Intelligence /marketintelligence/en/news-insights/trending/N9lms0nZ59bAqr_MEbTIfg2 content esgSubNav
In This List

Ultragenyx appoints independent director

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Ultragenyx appoints independent director

Ultragenyx Pharmaceutical Inc. appointed Deborah Dunsire to the company's board of directors.

Dunsire, currently president and CEO of XTuit Pharmaceuticals Inc., will serve as an independent director on Ultragenyx's board.